Imaging Intelligence Daily
Wednesday, March 18, 2026
Issue #9 · 6 signals
🔵 RESEARCH
Meta-Analysis Pits AI Against Radiologists for Prostate MRI
A European Radiology meta-analysis compared AI models with radiologists for detecting clinically significant prostate cancer on multiparametric MRI.
Prostate mpMRI suffers from limited specificity and inter-reader variability. This head-to-head evidence base will shape how health systems decide whether to deploy AI as a standalone reader or a second-opinion tool in prostate pathways.
🔵 RESEARCH
Expert Review Outlines POCUS for Heart Failure in Pregnancy
An expert review proposes a simplified qualitative-first POCUS approach for evaluating systolic heart failure during pregnancy and postpartum.
Obstetric patients with reduced ejection fraction often lack timely echocardiography access. This framework gives MFM and emergency clinicians a structured bedside protocol, extending the POCUS expansion seen in recent heart failure and ICU trials.
American journal of perinatology · 2026-03-17
Read more →
🔵 RESEARCH
Trial Compares Ultrasound Acquisition Methods for Fetal Screening
The Echo-IA trial compares two image acquisition modalities for second-trimester fetal morphology screening ultrasound.
Missed fetal malformations remain a key quality gap in obstetric imaging. Optimized acquisition techniques could improve anomaly detection rates and inform standardized scanning protocols across varying operator skill levels.
🔵 RESEARCH
Trial Tests AI-Guided EUS for Gallbladder Stent Placement
A prospective trial evaluates AI-assisted endoscopic ultrasound to guide lumen-apposing metal stent deployment for gallbladder drainage.
Stent placement under EUS is technically demanding with significant complication risk. AI procedural guidance represents a shift from diagnostic image interpretation to real-time interventional support — a higher-value integration point for ultrasound AI vendors.
🟢 FUNDING
FTC Pressure Kills Alcon's $356M Lensar Acquisition
Alcon abandoned its $356M deal to acquire Lensar's robotic laser cataract surgery systems after the FTC threatened to block it.
The blocked deal preserves competition in robotic cataract surgery systems and signals heightened FTC scrutiny of imaging-adjacent device consolidation. Coming one day after Sectra-Oxipit closed, it underscores divergent antitrust risk across imaging subsectors.
🔵 RESEARCH
NIH Publishes Machine Learning Analysis of CT Scans
The National Institutes of Health released research on machine learning analysis of CT scans for diagnostic imaging applications.
NIH-backed validation studies carry weight with regulators and payers. Federal investment in CT-based ML research supports the evidence base that commercial AI vendors need for broader clinical adoption.
Google News: CT scan artificial intelligenc · Tue, 17 Ma
Read more →
🩺 EDITOR’S TAKE — FOR CLINICIANS
Prostate mpMRI AI is reaching parity with radiologists on sensitivity, but specificity remains the bottleneck. Watch meta-analysis details closely before trusting standalone AI reads. Meanwhile, POCUS keeps expanding into new clinical niches — obstetric cardiology and interventional EUS are both worth tracking.
📊 EDITOR’S TAKE — FOR INVESTORS
The FTC's move to block Alcon-Lensar signals tougher antitrust scrutiny for imaging-adjacent device consolidation. Coming days after Sectra's Oxipit acquisition, deal teams should expect longer timelines and narrower market-definition arguments in ophthalmic and robotic surgical imaging.
🏭 EDITOR’S TAKE — FOR INDUSTRY
AI is moving beyond radiology reads into procedural guidance — EUS stent placement and obstetric POCUS represent workflow integration points where OEMs and software vendors can embed intelligence at the point of care rather than in post-hoc interpretation.